Interferon

Type: Keyphrase
Name: Interferon
First reported 1 hour ago - Updated 1 hour ago - 1 reports

Regulus Therapeutics: Gilead’s New Competitor?

Regulus Therapeutics released positive results for its hepatitis C drug candidate yesterday; Bidness Etc explores if the company can be a threat for GileadPage 1 of 2Click Ticker to See live coverageRegulus Therapeutics Inc ( RGLS ) exploded in the stock ... [Published Bidness Etc - 1 hour ago]
First reported 17 hours ago - Updated 17 hours ago - 1 reports

Biogen Idec's (BIIB) CEO George Scangos on Q3 2014 Results - Earnings Call Transcript

OperatorGood morning. My name is Tiffany and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen Idec Q3 2014 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. ... [Published Seeking Alpha - 17 hours ago]
Entities: TECFIDERA, Tysabri, PLEGRIDY
First reported Oct 21 2014 - Updated Oct 22 2014 - 3 reports

YEDA and XL-protein sign business collaboration agreement to commercialize PASylated interferon superagonist

(live-PR.com) - One of the potential uses of PAS-YNSa8 is for treating inflammatory diseases, in particular of the central nervous system. An example is multiple sclerosis (MS), a devastating chronic, progressive immune disease of the central nervous ... [Published Live-PR.com - Oct 22 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

HCV at ID Week-2 2014

".....These developments make a dialogue about a "treatment-as-prevention" strategy for HCV possible, although daunting obstacles to implementation still exist...."October 8-12, Philadelphia, PADavid H Shepp, MDAssociate Professor of MedicineHofstra-North ... [Published National AIDS Treatment Advocacy Project - Oct 21 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

Pricey Hepatitis Drug a Good Bet in U.S. Prisons, Study Says

Study results published in the Annals of Internal Medicine suggest that using Sovaldi (sofosbuvir) to treat prison inmates with hepatitis C is more cost-effective than Victrelis, as reported U.S. News & World. "It looks like the additional benefits of ... [Published FirstWord Pharma - Oct 21 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

Could the Hepatitis C Virus Be Eradicated in Your Lifetime?

With the introduction of interferon free therapies, it is possible that the hepatitis C infection may be cured or even eradicated within the next 10 to 20 years.Click to Continue » ... [Published Fort Mills Times - Oct 21 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

[Articles] Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study

Summary BackgroundMiddle East respiratory syndrome coronavirus (MERS-CoV) infection is associated with high mortality and has no approved antiviral therapy. We aimed to compare ribavirin and interferon alfa-2a treatment for patients with severe MERS-CoV ... [Published Lancet Infectious Diseases - Oct 21 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

Prisons balk at $84K cost for hepatitis C treatment

In San Francisco’s jails, no inmates with hepatitis C are receiving Sovaldi, the breakthrough pill that can cure most patients in an unprecedented amount of time.In California’s prisons, the drug, made by Gilead Sciences of Foster City, is being given ... [Published San Francisco Chronicle - Oct 21 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 1 reports

Ebola prompts faculty response

University of Toronto faculty are at the forefront of a global health response to the Ebola outbreak that has killed over 4,400 people.On October 14, the World Health Organization (WHO) said that the death rate of West African patients reached 70 per ... [Published The Varsity Online - Oct 20 2014]
First reported Oct 19 2014 - Updated Oct 19 2014 - 1 reports

Here's What Makes Ebola So Simple And Deadly

You can do a lot of damage with just seven genes EBOLA is a simple virus, but also a subtle one. This long, thin package, along with a large protein called a polymerase, is packed into a membrane that is studded with a glycoproteins--that is, proteins ... [Published Austin American Statesman - Oct 19 2014]
First reported Oct 19 2014 - Updated Oct 19 2014 - 1 reports

180 Million People Have This Disease, Yet Few Are Aware of It

Source: European Commission DG ECHO via FlickrInfectious diseases are everywhere, and according to Smart Global Health they're blamed for 16% of global deaths each year. Breaking these deaths down based on data from the World Health Organization, these ... [Published Motley Fool Discussion Boards - Oct 19 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 2 reports

FDA Approves Drug That Can Cure Hepatitis C In Eight Weeks

Pharmaceutical Company, Gilead Sciences is promising that nearly half of patients infected with hepatitis c can be cured after eight weeks of taking its new drug, Harvoni.Reuters has reported that the U.S. Food and Drug Administration (FDA) has approved ... [Published Inquisitr - Oct 16 2014]

Quotes

...isn’t until the dogs are bounding around on the front lawn after a short adoption ceremony that Brannon is able to get his first good look at them. "I’m impressed. They seem advanced for their age. But you don’t really know until a dog is 12 months what you have physically and mentally" Brannon says, which is why he doesn’t bother with the imprecise and wasteful process of breeding...
"Provided herein are methods of making a molecule for enzyme replacement therapy comprising conjugating a heterobifunctional crosslinking agent to a variant IGF-2 peptide and then conjugating the heterobifunctional crosslinking agent modified variant IGF-2 peptide to a recombinant human lysosomal enzyme."

More Content

All (653) | News (526) | Reports (0) | Blogs (122) | Audio/Video (0) | Fact Sheets (3) | Press Releases (1)
sort by: Date | Relevance
Regulus Therapeutics: Gilead’s New Competitor? [Published Bidness Etc - 1 hour ago]
Biogen Idec third-qtr net rockets 76% but share... [Published Pharma Letter - 2 hours ago]
Diplomat Pharmacy Inc's Harvoni (ledipasvir/sof... [Published Reuters UK - 2 hours ago]
Harvoni Approved For The Treatment Of Chronic H... [Published BioMedReports - 12 hours ago]
For $100,000, You Can Clone Your Dog [Published BusinessWeek - 12 hours ago]
Patent Application Titled "Methods for Coupling... [Published Pharmacy Choice - 12 hours ago]
Harvoni Approved For The Treatment Of Chronic H... [Published Benzinga.com - 15 hours ago]
Biogen Idec's (BIIB) CEO George Scangos on Q3 2... [Published Seeking Alpha - 17 hours ago]
Early Immune Responses in Rainbow Trout Liver u... [Published Plosone.org - 18 hours ago]
FDA News for Health Professionals - 10-22-2014 [Published Food Consumer - 18 hours ago]
Biogen MS superstar Tecfidera misses estimates;... [Published FiercePharma - 19 hours ago]
Biogen's Q3 Earnings Top Estimates, View Raised... [Published Zacks.com - 20 hours ago]
Multiple Sclerosis Management - update on the N... [Published Multiple Sclerosis Research - Oct 22 2014]
YEDA and XL-protein sign business collaboration... [Published Live-PR.com - Oct 22 2014]
Obama admin pushing use of aborted baby cells f... [Published One News Now - Oct 22 2014]
Why do I think the fingolimod primary progressi... [Published Multiple Sclerosis Research - Oct 22 2014]
HCV at ID Week-2 2014 [Published National AIDS Treatment Advocacy Project - Oct 21 2014]
Horizon Pharma plc to Host Third Quarter 2014 C... [Published MarketWired - Oct 21 2014]
Horizon Pharma plc to Host Third Quarter 2014 C... [Published BioSpace - Oct 21 2014]
3 Stocks That Could Surprise This Earnings Season [Published Motley Fool - Oct 21 2014]
Pricey Hepatitis Drug a Good Bet in U.S. Prison... [Published FirstWord Pharma - Oct 21 2014]
YEDA and XL-protein sign deal to commercialize ... [Published News-Medical.Net - Oct 21 2014]
YEDA-XL-Protein GmbH agreement [Published EurekAlert! - Oct 21 2014]
Aussies warned over hepatitis and medications [Published International Travel Insurance Journal - Oct 21 2014]
Synairgen PLC's potential is Astra-nomical [Published Proactive Investors.co.uk - Oct 21 2014]
3 Drugs Critical to Johnson & Johnson's Future [Published Motley Fool Discussion Boards - Oct 21 2014]
Could the Hepatitis C Virus Be Eradicated in Yo... [Published Fort Mills Times - Oct 21 2014]
Could the Hepatitis C Virus Be Eradicated in Yo... [Published 4 Traders - Oct 21 2014]
Vitamin C kills viruses [Published Jamaica Gleaner - Oct 21 2014]
GILEAD SCIENCES : Health Canada Issues Notice o... [Published 4 Traders - Oct 21 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Multiple Sclerosis Management - update on the N... [Published Multiple Sclerosis Research - Oct 22 2014]
Multiple sclerosis: management of multiple sclerosis in primary and secondary care - published Oct 2014 https://www.nice.org.uk/guidance/cg186 This guideline replaces the clinical guideline published in 2003 (i.e. NICE or the National Insitute ...
Why do I think the fingolimod primary progressi... [Published Multiple Sclerosis Research - Oct 22 2014]
Will the fingolimod PPMS trial disprove my hypothesis about progressive MS? #MSBlog #MSResearch Have you heard about asynchronous progressive MS hypothesis? #MSBlog #MSResearch "You may recall the post I did on a study of interferon-beta treatment ...
How Ebola evades and suppresses immune responses [Published H5N1 - Oct 19 2014]
Thanks to Greg Folkers for sending the link to this article in Cell: Camouflage and Misdirection: The Full-On Assault of Ebola Virus Disease. The summary:Ebolaviruses cause a severe hemorrhagic fever syndrome that is rapidly fatal to humans and nonhuman ...
OffLabel: mitoxantrone for highly-active MS [Published Multiple Sclerosis Research - Oct 17 2014]
Mitoxantrone is number 3 on my off-label essential MS DMT list. #MSBlog #MSResearch #OffLabel "This post is the third in a series of posts to try and help neurologists who treat MS in healthcare environments where they cannot access high-cost innovator ...
What caused the MERS outbreak in Saudi Arabia l... [Published H5N1 - Oct 17 2014]
Thanks to Greg Folkers for sending the link to this report in Clinical Infectious Diseases: An observational, laboratory-based study of outbreaks of MERS-Coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014. The authors include Christian Drosten, ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Hemispherx Biopharma and Bioclones Join Forces ... [Published GlobeNewswire: Acquisitions News - Jul 08 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.